Острые и отдаленные неврологические нарушения у пациентов, перенесших коронавирусную инфекцию
https://doi.org/10.14412/2074-2711-2022-3-4-11
Аннотация
В настоящее время за консультацией к неврологу обращаются пациенты, которые связывают свои жалобы и расстройства с перенесенным COVID-19. Следует учитывать опасные осложнения COVID-19, такие как инсульт, включая церебральный венозный тромбоз, аутоиммунный энцефалит и миелит, синдром задней обратимой энцефалопатии, синдром Гийена–Барре. Значительно чаще в остром периоде COVID-19 встречаются расстройства сознания, нарушения обоняния и вкуса, головная боль и головокружение. Длительное сохранение жалоб и расстройств после перенесенного COVID-19 расценивается как постковидный синдром (ПКС). Неврологические жалобы и нарушения у пациента, перенесшего COVID-19, часто вызваны развитием или обострением сочетанного заболевания, включая первичную головную боль, скелетно-мышечную боль в шее и спине, различные вестибулярные нарушения, болезнь Альцгеймера, тревожные и депрессивные расстройства. К сожалению, в реальной клинической практике эти заболевания часто не диагностируются, пациенты наблюдаются с диагнозом ПКС, при этом не учитывается, что основа диагностики ПКС – исключение других заболеваний, которыми можно объяснить жалобы и расстройства у пациента, перенесшего COVID-19.
Об авторах
В. А. Парфенов
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И. М. Сеченова» Минздрава России (Сеченовский Университет)
Россия
Россия
Кафедра нервных болезней и нейрохирургии Института клинической медицины им. Н. В. Склифосовского
119021, Москва, ул. Россолимо, 11, стр. 1
А. А. Кулеш
ФГБОУ ВО «Пермский государственный медицинский университет им. акад. Е. А. Вагнера» Минздрава России
Россия
Россия
614990, Пермь, ул. Петропавловская, 26
Список литературы
1. Stefanou MI, Palaiodimou L, Bakola E, et al. Neurological manifestations of long- COVID syndrome: a narrative review. Ther Adv Chronic Dis. 2022 Feb 17;13:20406223221076890. doi: 10.1177/20406223221076890
2. Долгополов ИС, Менткевич ГЛ, Рыков МЮ, Чичановская ЛВ. Неврологические нарушения у пациентов с long COVID синдромом и методы клеточной терапии для их коррекции: обзор литературы. Сеченовский вестник. 2021;12(3):56-67. doi: 10.47093/2218-7332.2021.12.3.56-67
3. Белопасов ВВ, Яшу Я, Самойлова ЕМ, Баклаушев ВП. Поражение нервной системы при СOVID-19. Клиническая практика. 2020;11(2):60-80. doi: 10.17816/clinpract34851
4. Родионова ОВ, Сорокоумов ВА. Неврологические заболевания в условиях пандемии COVID-19 (обзор литературы). Ученые записки Санкт-Петербургского государственного медицинского университета имени академика И.П. Павлова. 2020;27(2):18-24. doi: 10.24884/1607-4181-2020-27-2-18-24
5. Холин АА, Заваденко НН, Нестеровский ЮЕ и др. Особенности неврологических проявлений COVID-19 у детей и взрослых. Журнал неврологии и психиатрии им. С.С. Корсакова. 2020;120(9):114-20. doi: 10.17116/jnevro2020120091114
6. Никитина АЮ, Чимагомедова АШ, Левин ОС. Неврологические проявления COVID-19 у пожилых. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2021;121(10-2):5-15. doi: 10.17116/jnevro20211211025
7. Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017 Aug;264(8):1608-16. doi: 10.1007/s00415-016-8377-8
8. Iodice F, Cassano V, Rossini PM. Direct and indirect neurological, cognitive, and behavioral effects of COVID-19 on the healthy elderly, mild-cognitive-impairment, and Alzheimer's disease populations. Neurol Sci. 2021 Feb;42(2):455-65. doi: 10.1007/s10072-020-04902-8
9. Cheng Q, Yang Y, Gao J. Infectivity of human coronavirus in the brain. EBioMedicine. 2020 Jun;56:102799. doi: 10.1016/j.ebiom.2020.102799
10. Politi LS, Salsano E, Grimaldi M. Magnetic Resonance Imaging Alteration of the Brain in a Patient with Coronavirus Disease 2019 (COVID-19) and Anosmia. JAMA Neurol. 2020 Aug 1;77(8):1028-9. doi: 10.1001/jamaneurol.2020.2125
11. Aragao MFVV, Leal MC, Cartaxo Filho OQ, et al. Anosmia in COVID-19 Associated with Injury to the Olfactory Bulbs Evident on MRI. AJNR Am J Neuroradiol. 2020 Sep;41(9):1703-6. doi: 10.3174/ajnr.A6675
12. Chiu A, Fischbein N, Wintermark M, et al. COVID-19-induced anosmia associated with olfactory bulb atrophy. Neuroradiology. 2021 Jan;63(1):147-8. doi: 10.1007/s00234-020-02554-1. Epub 2020 Sep 15.
13. Schweitzer F, Goereci Y, Franke C, et al. Cerebrospinal Fluid Analysis Post-COVID-19 Is Not Suggestive of Persistent Central Nervous System Infection. Ann Neurol. 2022 Jan;91(1):150-7. doi: 10.1002/ana.26262. Epub 2021 Nov 22.
14. Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol. 2020 Sep;19(9):767-83. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.
15. Cui Y, Zhao B, Li T, et al. Risk of ischemic stroke in patients with COVID-19 infection: A systematic review and meta-analysis. Brain Res Bull. 2022 Mar;180:31-7. doi: 10.1016/j.brainresbull.2021.12.011. Epub 2021 Dec 31.
16. Luo W, Liu X, Bao K, Huang C. Ischemic stroke associated with COVID-19: a systematic review and meta-analysis. J Neurol. 2022 Apr;269(4):1731-40. doi: 10.1007/s00415-021-10837-7. Epub 2021 Oct 15.
17. Tan YK, Goh C, Leow AST, et al. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis. 2020 Oct;50(3):587-95. doi: 10.1007/s11239-020-02228-y
18. Ntaios G, Michel P, Georgiopoulos G, et al. Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke Registry. Stroke. 2020 Sep;51(9):e254-e258. doi: 10.1161/STROKEAHA.120.031208. Epub 2020 Jul 9.
19. Spence JD, de Freitas GR, Pettigrew LC, et al. Mechanisms of Stroke in COVID-19. Cerebrovasc Dis. 2020;49(4):451-8. doi: 10.1159/000509581. Epub 2020 Jul 20.
20. Hess DC, Eldahshan W, Rutkowski E. COVID-19-Related Stroke. Transl Stroke Res. 2020 Jun;11(3):322-5. doi: 10.1007/s12975-020-00818-9. Epub 2020 May 7.
21. Tsivgoulis G, Palaiodimou L, Zand R, et al. COVID-19 and cerebrovascular diseases: a comprehensive overview. Ther Adv Neurol Disord. 2020 Dec 8;13:1756286420978004. doi: 10.1177/1756286420978004. eCollection 2020.
22. Baldini T, Asioli GM, Romoli M, et al. Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: A systematic review and meta-analysis. Eur J Neurol. 2021 Oct;28(10):3478-90. doi: 10.1111/ene.14727. Epub 2021 Feb 2.
23. Payus AO, Jeffree MS, Ohn MH, et al. Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19. Neurol Sci. 2022 Mar;43(3):1533-47. doi: 10.1007/s10072-021-05785-z. Epub 2021 Dec 1.
24. Esmaeili S, Abbasi MH, Joghataei MT, et al. Acute disseminated encephalitis (ADEM) as the first presentation of COVID-19; a case report. Ann Med Surg (Lond). 2022 Mar28;77:103511. doi: 10.1016/j.amsu.2022.103511. eCollection 2022 May.
25. Gelibter S, Bellavia G, Arbasino C, et al. Encephalopathy as a prognostic factor in adults with acute disseminated encephalomyelitis following COVID-19. J Neurol. 2022 May;269(5):2293-300. doi: 10.1007/s00415-021-10947-2. Epub 2022 Jan 3.
26. Oumerzouk J, Nabil M, Klevor R, et al. Clinicoradiological and prognostic features of COVID-19-associated acute disseminated encephalomyelitis. Rev Neurol (Paris). 2022 Jan-Feb;178(1-2):144-50. doi: 10.1016/j.neurol.2021.11.003. Epub 2021 Nov 27.
27. Ali L, Mohammed I, Zada Y, et al. COVID-19-Associated Acute Transverse Myelitis: A Case Series of a Rare Neurologic Condition. Cureus. 2021 Oct 6;13(10):e18551. doi: 10.7759/cureus.18551. eCollection 2021 Oct.
28. Qazi R, Memon A, Mohamed AS, et al. Post-COVID-19 Acute Transverse Myelitis: A Case Report and Literature Review. Cureus. 2021 Dec 22;13(12):e20628. doi: 10.7759/cureus.20628. eCollection 2021 Dec.
29. Prete S, McShannic JD, Fertel BS, Simon EL. Acute transverse myelitis progressing to permanent quadriplegia following COVID-19 infection. Am J Emerg Med. 2022 Feb 23:S0735-6757(22)00123-1. doi: 10.1016/j.ajem.2022.02.038. Online ahead of print.
30. Roman GC, Gracia F, Torres A, et al. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222). Front Immunol. 2021 Apr26;12:653786. doi: 10.3389/fimmu.2021.653786. eCollection 2021.
31. Iftikhar S, Rehman AU, Ameer MZ, et al. The association of posterior reversible encephalopathy syndrome with COVID-19: A systematic review. Ann Med Surg (Lond). 2021 Dec;72:103080. doi: 10.1016/j.amsu.2021.103080. Epub 2021 Nov 20.
32. Palaiodimou L, Stefanou MI, Katsanos AH, et al. Prevalence, clinical characteristics and outcomes of Guillain-Barrе syndrome spectrum associated with COVID-19: A systematic review and meta-analysis. Eur J Neurol. 2021 Oct;28(10):3517-29. doi: 10.1111/ene.14860. Epub 2021 Apr 28.
33. Ahmed JO, Ahmad SA, Hassan MN, et al. Post COVID-19 neurological complications; a meta-analysis. Ann Med Surg (Lond). 2022 Apr;76:103440. doi: 10.1016/j.amsu.2022.103440. Epub 2022 Mar 3.
34. Bohania N, Ish P, Nune A, Iyengar KP. Cranial neuropathy in COVID-19: a case series and review of literature. Infez Med. 2021 Dec 10;29(4):609-13. doi: 10.53854/liim-2904-15. eCollection 2021.
35. Tamaki A, Cabrera CI, Li S, et al. Incidence of Bell Palsy in Patients With COVID-19. JAMA Otolaryngol Head Neck Surg. 2021 Aug 1;147(8):767-8. doi: 10.1001/jamaoto.2021.1266
36. Gupta S, Jawanda MK, Taneja N, Taneja T. A systematic review of Bell's Palsy as the only major neurological manifestation in COVID-19 patients. J Clin Neurosci. 2021 Aug;90:284-92. doi: 10.1016/j.jocn.2021.06.016. Epub 2021 Jun 21.
37. Martin-Villares C, Alba JR, Gonzalez-Gimeno MJ. Data from 235 Cases of Bell's Palsy during COVID-19 Pandemic: Were There Clusters of Facial Palsy? Neuroepidemiology. 2021;55(6):495-6. doi: 10.1159/000518671. Epub 2021 Sep 8.
38. Halalau A, Halalau M, Carpenter C, et al. Vestibular neuritis caused by severe acute respiratory syndrome coronavirus 2 infection diagnosed by serology: Case report. SAGE Open Med Case Rep. 2021 May 13;9:2050313X211013261. doi: 10.1177/2050313X211013261. eCollection 2021.
39. Babu TA, Sarkar MK, Sharmila V. COVID-19 vestibular neuritis (CVN) in a healthcare worker: a rare complication of COVID-19 infection. J R Coll Physicians Edinb. 2021 Jun;51(2):199-207. doi: 10.4997/JRCPE.2021.224
40. Kumar S, Veldhuis A, Malhotra T. Neuropsychiatric and Cognitive Sequelae of COVID-19. Front Psychol. 2021 Mar2;12:577529. doi: 10.3389/fpsyg.2021.577529. eCollection 2021.
41. Yassin A, Nawaiseh M, Shaban A, et al. Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. BMC Neurol. 2021 Mar 30;21(1):138. doi: 10.1186/s12883-021-02161-4
42. Stracciari A, Bottini G, Guarino M, et al; “Cognitive and Behavioral Neurology” Study Group of the Italian Neurological Society. Cognitive and behavioral manifestations in SARS-CoV-2 infection: not specific or distinctive features? Neurol Sci. 2021 Jun;42(6):2273-81. doi: 10.1007/s10072-021-05231-0. Epub 2021 Apr 12.
43. Jaywant A, Vanderlind WM, Alexopoulos GS, et al. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology. 2021 Dec;46(13):2235-40. doi: 10.1038/s41386-021-00978-8. Epub 2021 Feb 15.
44. Mazza MG, Palladini M, De Lorenzo R, et al; COVID-19 BioB Outpatient Clinic Study group. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at threemonth follow-up. Brain Behav Immun. 2021 May;94:138-47. doi: 10.1016/j.bbi.2021.02.021. Epub 2021 Feb 24.
45. Mattioli F, Stampatori C, Righetti F, et al. Neurological and cognitive sequelae of COVID-19: a four month follow-up. J Neurol. 2021 Dec;268(12):4422-8. doi: 10.1007/s00415-021-10579-6. Epub 2021 May 1.
46. Mattioli F, Piva S, Stampatori C, et al. Neurologic and cognitive sequelae after SARSCoV2 infection: Different impairment for ICU patients. J Neurol Sci. 2022 Jan15;432:120061. doi: 10.1016/j.jns.2021.120061. Epub 2021 Nov 26.
47. Frontera JA, Yang D, Lewis A, et al. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J Neurol Sci. 2021 Jul15;426:117486. doi: 10.1016/j.jns.2021.117486. Epub 2021 May 12.
48. Hosp JA, Dressing A, Blazhenets G, et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021 May 7;144(4):1263-76. doi: 10.1093/brain/awab009
49. Liu YH, Chen Y, Wang QH, et al. One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study. JAMA Neurol. 2022 Mar8:e220461. doi: 10.1001/jamaneurol.2022.0461
50. Frontera JA, Yang D, Medicherla C, et al. Trajectories of Neurologic Recovery 12 Months After Hospitalization for COVID-19: A Prospective Longitudinal Study. Neurology. 2022 Mar 21:10.1212/WNL.0000000000200356. doi: 10.1212/WNL.0000000000200356. Online ahead of print.
51. Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022 Apr;604(7907):697-707. doi: 10.1038/s41586-022-04569-5. Epub 2022 Mar 7.
52. Voruz P, Cionca A, Jacot de Alcantara I, et al. Functional connectivity underlying cognitive and psychiatric symptoms in post- COVID-19 syndrome: is anosognosia a key determinant? Brain Commun. 2022 Mar 9;4(2):fcac057. doi: 10.1093/braincomms/fcac057
53. Renaud-Charest O, Lui LMW, Eskander S, et al. Onset and frequency of depression in post-COVID-19 syndrome: A systematic review. J Psychiatr Res. 2021 Dec;144:129-37. doi: 10.1016/j.jpsychires.2021.09.054
54. Jafari Z, Kolb BE, Mohajerani MH. Hearing Loss, Tinnitus, and Dizziness in COVID-19: A Systematic Review and Meta-Analysis. Can J Neurol Sci. 2022 Mar;49(2):184-95. doi: 10.1017/cjn.2021.63
55. Gallus R, Melis A, Rizzo D, et al. Audiovestibular symptoms and sequelae in COVID-19 patients. J Vestib Res. 2021;31(5):381-7. doi: 10.3233/VES-201505
56. Almishaal AA, Alrushaidan AA. Shortand Long-Term Self-Reported Audiovestibular Symptoms of SARS-CoV-2 Infection in Hospitalized and Nonhospitalized Patients. Audiol Neurootol. 2022 Mar 3:1-15. doi: 10.1159/000521963. Online ahead of print.
57. Viola P, Ralli M, Pisani D, et al. Tinnitus and equilibrium disorders in COVID-19 patients: preliminary results. Eur Arch Otorhinolaryngol. 2021 Oct;278(10):3725-30. doi: 10.1007/s00405-020-06440-7
58. Daher GS, Nassiri AM, Vanichkachorn G, et al. New onset tinnitus in the absence of hearing changes following COVID-19 infection. Am J Otolaryngol. 2022 Jan- Feb;43(1):103208. doi: 10.1016/j.amjoto.2021.103208
59. Garcia-Azorin D, Layos-Romero A, Porta-Etessam J, et al. Post-COVID-19 persistent headache: A multicentric 9-months followup study of 905 patients. Cephalalgia. 2022 Feb 15:3331024211068074. doi: 10.1177/03331024211068074
60. Fernandez-de-Las-Penas C, Navarro-Santana M, Gomez-Mayordomo V, et al. Headache as an acute and post- COVID-19 symptom in COVID-19 survivors: A meta-analysis of the current literature. Eur J Neurol. 2021 Nov;28(11):3820-5. doi: 10.1111/ene.15040
61. Wang L, Yang N, Yang J, et al. A Review: The Manifestations, Mechanisms, and Treatments of Musculoskeletal Pain in Patients with COVID-19. Front Pain Res (Lausanne). 2022 Mar10;3:826160. doi: 10.3389/fpain.2022.826160
62. Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020 Feb 19;368:m606. doi: 10.1136/bmj.m606
63. Lippi G, Wong J, Henry BM. Myalgia may not be associated with severity of coronavirus disease 2019 (COVID-19). World J Emerg Med. 2020;11(3):193-4. doi: 10.5847/wjem.j.1920-8642.2020.03.013
64. Tuzun S, Keles A, Okutan D, et al. Assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with COVID-19. Eur J Phys Rehabil Med. 2021 Aug;57(4):653-62. doi: 10.23736/S1973-9087.20.06563-6
65. Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021 Jan 22;372:n136. doi: 10.1136/bmj.n136
66. Fernandez-de-Las-Penas C, Navarro-Santana M, Plaza-Manzano G, et al. Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived to severe acute respiratory syndrome coronavirus 2 infection: a systematic review and meta-analysis. Pain. 2021 Sep 23. doi: 10.1097/j.pain.0000000000002496. Online ahead of print.
67. Fernandez-de-Las-Penas C, de-la-Llave-Rincon AI, Ortega-Santiago R, et al. Prevalence and risk factors of musculoskeletal pain symptoms as long-term post- COVID sequelae in hospitalized COVID-19 survivors: a multicenter study. Pain. 2021 Dec 10. doi: 10.1097/j.pain.0000000000002564. Online ahead of print.
68. Suresh K, Alam MDU, Satkovich E. COVID-19-Associated Dysautonomia. Cureus. 2021 Aug 13;13(8):e17156. doi: 10.7759/cureus.17156. eCollection 2021 Aug.
69. Shouman K, Vanichkachorn G, Cheshire WP, et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021 Jun;31(3):385-94. doi: 10.1007/s10286-021-00803-8. Epub 2021 Apr 16.
70. Chadda KR, Blakey EE, Huang CL, Jeevaratnam K. Long COVID-19 and Postural Orthostatic Tachycardia Syndrome – Is Dysautonomia to Be Blamed? Front Cardiovasc Med. 2022 Mar9;9:860198. doi: 10.3389/fcvm.2022.860198. eCollection 2022.
71. Blitshteyn S, Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. 2021 Apr;69(2):205-11. doi: 10.1007/s12026-021-09185-5
72. COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (NICE); 2020 Dec 18.
73. Bliddal S, Banasik K, Pedersen OB, et al. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci Rep. 2021 Jun 23;11(1):13153. doi: 10.1038/s41598-021-92045-x
74. Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021 Aug;38:101019. doi: 10.1016/j.eclinm.2021.101019. Epub 2021 Jul 15.
75. Anaya JM, Rojas M, Salinas ML, et al. Post-COVID syndrome. A case series and comprehensive review. Autoimmun Rev. 2021 Nov;20(11):102947. doi: 10.1016/j.autrev.2021.102947
76. Rass V, Beer R, Schiefecker AJ, et al. Neurological outcomes 1 year after COVID-19 diagnosis: A prospective longitudinal cohort study. Eur J Neurol. 2022 Jun;29(6):1685-96. doi: 10.1111/ene.15307. Epub 2022 Mar 23.
Рецензия
Для цитирования:
Парфенов ВА, Кулеш АА. Острые и отдаленные неврологические нарушения у пациентов, перенесших коронавирусную инфекцию. Неврология, нейропсихиатрия, психосоматика. 2022;14(3):4-11. https://doi.org/10.14412/2074-2711-2022-3-4-11
For citation:
Parfenov VA, Kulesh AA. Acute and long-term neurological disorders in patients with coronavirus infection. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2022;14(3):4-11. https://doi.org/10.14412/2074-2711-2022-3-4-11
Просмотров:
801
Послать статью по эл. почте 